MedTrace Logo

MBC Physical Activity Study

NCT06500858 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-11-21

No results posted yet for this study

Summary

This clinical trial evaluates the impact of a tailored physical activity program on physical activity in patients with breast cancer that has spread from where it first started to other places in the body (metastatic). It has been shown that decreased physical activity contributes to poor performance and quality of life. Evidence has also shown that exercise could improve physical fitness, physical functioning, quality of life, and cancer-related fatigue, however, there is concern that it may not be available to those with physical limitations. The proposed physical activity program offers a comprehensive and individualized assessment for each metastatic breast cancer patient and includes a high quality, tailored exercise home-based program designed by an advanced qualified cancer exercise specialist. A tailored physical activity program may improve physical activity in metastatic breast cancer patients.

Conditions

  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Breast Carcinoma

Interventions

OTHER

Exercise Intervention

Receive a welcome package with exercise equipment

OTHER

Exercise Intervention

Participate in virtual-exercise sessions

OTHER

Exercise Intervention

Receive access to optional drop-in classes

OTHER

Health Promotion and Education

Receive monthly newsletters

OTHER

Internet-Based Intervention

Receive access to online fitness buddy matching program

OTHER

Physical Activity

Participate in a walking program

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • Thomas Jefferson University

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-06
Primary Completion
2025-10-30
Completion
2025-10-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06500858 on ClinicalTrials.gov